TY - JOUR AU - Gianni, L; Pienkowski, T; Im, YH TI - Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial JO - Lancet Oncol VL - 13 PY - 2012 DO - 10.1016/S1470-2045(11)70336-9 L3 - PubMed-ID: 22153890 L3 - PubMed-ID: 22153890 SP - 25 EP - 32 N1 - et al. ER -